European Science Editing 46: e54172, doi: 10.3897/ese.2020.e54172
Building transparency and trust in industry-sponsored clinical research through open access publishing
expand article infoBarbara DeCastro, Anna Geraci§, Jayme Trott|, G. Peter Snyder, Yaswant Dayaram#
‡ GlaxoSmithKline, Collegeville, United States of America§ International Society for Medical Publication Professionals, Tarrytown, United States of America| Janssen Global Services, LLC, Raritan, United States of America¶ AstraZeneca, Gaithersburg, United States of America# Bayer HealthCare Pharmaceuticals, Whippany, United States of America
Open Access

A desire for both transparency in research and widespread access to the results of research has led to activism in support of open access publishing. Open access publishing, particularly publishing industry-sponsored research, can be complex. The overarching benefits of, and challenges to, open access are described, illustrated with the initiatives related to Medical Publishing Insights and Practices to help promote a better understanding of open access and its importance in ensuring transparency in industry-sponsored research.

Industry-sponsored research, MPIP, Open Access, Transparency